Here we demonstrated that leukemic cells from U-CLL patients, that develop aggressive forms of the disease (Kipps et al., 2017), as well as from Eμ-TCL1 mice with overt leukemia, express the highest surface amounts of PD-L1 and harbor the most relevant IS-suppressive activity. Here, CD274 is linked to B-cell chronic lymphocytic leukemia.